1. 2 NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE DURING PROLONGED VENTILATION AFFECTS PULMONARY EXPRESSION OF STAT3 AND ITS DOWNSTREAM TARGET SOCS3 IN THE PREMATURE LUNG. Issue 1 (1st January 2007) Authors: Wilkinson, B.; Metcalfe, D.; Callaway, C.; Dahl, M. J.; McKnight, R. A.; Lane, R. H.; Albertine, K. H. Journal: Journal of investigative medicine Issue: Volume 55:Issue 1(2007) Page Start: S76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 337 NASAL CONTINUOUS POSITIVE AIRWAY PRESSURE DURING PROLONGED VENTILATION AFFECTS PULMONARY EXPRESSION OF STAT3 AND ITS DOWNSTREAM TARGET SOCS3 IN THE PREMATURE LUNG. Issue 1 (1st January 2007) Authors: Wilkinson, B.; Metcalfe, D.; Callaway, C.; Dahl, M. J.; McKnight, R. A.; Lane, R. H.; Albertine, K. H. Journal: Journal of investigative medicine Issue: Volume 55:Issue 1(2007) Page Start: S131 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. FRI0178 Estimated Medical Expenditures among Patients with Rheumatoid Arthritis Undergoing Treatment with Tofacitinib, an Oral Janus Kinase Inhibitor. (10th June 2014) Authors: Rendas-Baum, R.; Kosinski, M.; Singh, A.; Mebus, C.; Wilkinson, B.; Riese, R.; Wallenstein, G. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. OP0046 Tofacitinib, an Oral Janus Kinase Inhibitor, in a Rheumatoid Arthritis Open-Label Extension Study Following Adalimumab Therapy in a Phase 3 Randomised Clinical Trial. (23rd January 2014) Authors: Genovese, M.; van Vollenhoven, R.; Wilkinson, B.; Wang, L.; Zwillich, S.; Gruben, D.; Benda, B.; Jones, T.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. OP0152 Effects of Tofacitinib Monotherapy versus Methotrexate on Patient-Reported Outcomes in the 2-Year Phase 3 Oral Start TRIAL in Methotrexate-NaÏVe Patients with Rheumatoid Arthritis. (10th June 2014) Authors: Alten, R.; Strand, V.; Fleischmann, R.; Koncz, T.; Zwillich, S.; Bradley, J.; Gruben, D.; Wilkinson, B.; Krishnaswami, S.; Wallenstein, G. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. OP0163 Evaluation of Influenza and Pneumococcal Vaccine Responses in Rheumatoid Arthritis Patients Using Tofacitinib. (23rd January 2014) Authors: Winthrop, K. L.; Neal, J.; Hrycaj, P.; Soma, K.; Wilkinson, B.; Hodge, J.; Zwillich, S. H.; Wang, T.; Rottinghaus, S.; Kawabata, T.; Riese, R.; Mebus, C.; Bradley, J. D.; Bingham, C. O. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SAT0222 Effects of Tofacitinib on MRI Endpoints in Methotrexate-Naive Early Rheumatoid Arthritis: A Phase 2 MRI Study with Semi-Quantitative and Quantitative Endpoints. (9th June 2015) Authors: Conaghan, P.G.; Østergaard, M.; Bowes, M.A.; Wu, C.; Fuerst, T.; van der Heijde, D.; Hrycaj, P.; Xie, Z.; Zhang, R.; Wyman, B.T.; Bradley, J.; Soma, K.; Wilkinson, B. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 738 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Satellite-derived bathymetry using machine learning and optimal Sentinel-2 imagery in South-West Florida coastal waters. Issue 1 (31st December 2022) Authors: Mudiyanselage, S.S.J.D.; Abd-Elrahman, A.; Wilkinson, B.; Lecours, V. Journal: GIScience & remote sensing Issue: Volume 59:Issue 1(2022) Page Start: 1143 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. THU0151 Effects of tofacitinib (CP-690, 550), an oral janus kinase inhibitor, or adalimumab on patient reported outcomes in a phase 3 study of active rheumatoid arthritis. (23rd January 2014) Authors: van Vollenhoven, R.F.; Wallenstein, G.; Lee, E.B.; Fleischmann, R.; Zwillich, S.H.; Gruben, D.; Koncz, T.; Bradley, J.; Wilkinson, B.; Strand, V. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 206 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. THU0180 Lack of Early Change in Disease Activity Score Predicts The Likelihood of Achieving Low Disease Activity at Month 6: Tofacitinib Monotherapy versus Methotrexate in Methotrexate-Naïve Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Keystone, E.; van Vollenhoven, R.F.; Wilkinson, B.; Fallon, L.; Hwang, L.-J.; Chapman, D.; DeMasi, R.; Lee, E.B. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗